Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
Three Reddit-favored speculative bets face pivotal catalysts as spring gains fade. Archer Aviation, Rigetti Computing...
As economists debate the timing of a downturn, real-time indicators suggest that the market moves first and the headl...
ExxonMobil stock near $150 highlights a broader earnings and cash-flow story that many retail investors overlook. Her...
Apple’s board approved a fresh $100 billion buyback as Q2 2026 results beat expectations, underscoring the tech giant...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
GitLab posted its Q4 FY2026 results after the bell, showing revenue and earnings that set the stage for 2027. Stocks ...
Non-US markets rebound as the dollar weakens, prompting retirees to seek ESG-friendly exposure that also delivers div...